P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)

BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumor. Survival in GBM has remained essentially unchanged since 2005 despite numerous clinical Phase 3 trials conducted. Tumor treating fields (TTFields) are low-intensity, intermediate frequency, alternating electric fields t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Poster Presentations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144436/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.137
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak